SHOULDER INNOVATIONS, INC. Increase (Decrease) in Inventories
SHOULDER INNOVATIONS, INC. (SI) reported Increase (Decrease) in Inventories of $1.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $1.09M, a 72.57% decline year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $238.00K.
- SHOULDER INNOVATIONS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $2.23M, a 36.66% increase year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $2.28M, a 64.17% increase year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in inventories for fiscal 2025 was $7.64M, a 89.38% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. increase (decrease) in inventories for fiscal 2024 was $4.03M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.33M 10-Q · filed 2026-08-06 | $3.56M derived: sum of 3 quarters · filed 2026-08-06 | $5.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $238.00K 10-Q · filed 2026-05-13 | $2.47M derived: sum of 2 quarters · filed 2026-05-13 | $4.75M derived: sum of 3 quarters · filed 2026-05-13 | $8.72M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $4.51M derived: sum of 2 quarters · filed 2026-03-10 | $8.49M derived: sum of 3 quarters · filed 2026-08-06 | $7.64M 10-K · filed 2026-03-10 |
| 2025-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $6.25M derived: sum of 2 quarters · filed 2026-08-06 | $5.40M 10-Q · filed 2025-11-12 | $7.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.13M 10-Q · filed 2026-08-06 | $4.76M derived: sum of 3 quarters · filed 2026-08-06 | $6.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$851.00K 10-Q · filed 2026-05-13 | $783.00K derived: sum of 2 quarters · filed 2026-05-13 | $2.17M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $3.02M derived: sum of 2 quarters · filed 2026-03-10 | $4.03M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.40M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $1.01M 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |